Inventor
SCOTT E. STROME
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides19%
C12NMicroorganisms or enzymes19%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C12YEnzymes5%
PatentTitleYear
12,528,853T-cell receptor for treating fibrolamellar hepatocellular carcinoma202611,939,378Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target202411,440,946Universal antibody-mediated biosensor202211,242,387Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to MAYO FOUND MEDICAL EDUCATION & RES (2)· patent assignee history
2022–2026Patents assigned to UNIV MARYLAND (2)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to ST JUDE CHILDRENS RES HOSPITAL INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MAYO FOUND MEDICAL EDUCATION & RES | 2 | 2022–2024 |
| UNIV MARYLAND | 2 | 2022–2026 |
| ST JUDE CHILDRENS RES HOSPITAL INC | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2026 |